Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Evolus (EOLS) Change in Accured Expenses (2018 - 2025)

Historic Change in Accured Expenses for Evolus (EOLS) over the last 8 years, with Q3 2025 value amounting to $2.5 million.

  • Evolus' Change in Accured Expenses rose 1652.78% to $2.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$4.4 million, marking a year-over-year decrease of 15391.53%. This contributed to the annual value of $7.0 million for FY2024, which is 2223.08% down from last year.
  • Latest data reveals that Evolus reported Change in Accured Expenses of $2.5 million as of Q3 2025, which was up 1652.78% from $1.3 million recorded in Q2 2025.
  • In the past 5 years, Evolus' Change in Accured Expenses ranged from a high of $11.8 million in Q2 2021 and a low of -$14.2 million during Q1 2025
  • In the last 5 years, Evolus' Change in Accured Expenses had a median value of $2.2 million in 2024 and averaged $1.1 million.
  • In the last 5 years, Evolus' Change in Accured Expenses tumbled by 35552.67% in 2022 and then skyrocketed by 27836.14% in 2024.
  • Quarter analysis of 5 years shows Evolus' Change in Accured Expenses stood at $6.6 million in 2021, then crashed by 177.61% to -$5.1 million in 2022, then skyrocketed by 239.52% to $7.1 million in 2023, then decreased by 17.23% to $5.9 million in 2024, then crashed by 57.17% to $2.5 million in 2025.
  • Its Change in Accured Expenses stands at $2.5 million for Q3 2025, versus $1.3 million for Q2 2025 and -$14.2 million for Q1 2025.